Patent classifications
C
C07
C07F
9/00
C07F9/02
C07F9/28
C07F9/54
C07F9/5435
C07F9/5435
Mitochondria-targeted atovagone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug
12594283
·
2026-04-07
·
·
The present invention provides novel mitochondria-targeted Atovaquone compounds (Mito-ATO), a mitochondria-targeted derivative of Atovaquone, and methods of using such compounds. Methods of treating cancer using mito-ATO are also provided. Methods of enhancing an anti-tumor immune response by administering mito-ATO are further provided.